DLA Piper advises FastMed in its acquisition of CareSpot and MedPost Urgent Care
DLA Piper represented FastMed, one of the largest urgent care providers in the US, in its recent acquisition of Tenet Healthcare’s urgent care platform, which includes 87 CareSpot and MedPost clinics in Arizona, California, Florida and Texas.
With this expansion, FastMed is now one of the nation’s largest urgent care providers, with 192 total clinics. The addition of CareSpot and MedPost urgent care clinics enables FastMed to increase patient access to its unique model of high-quality, convenient, affordable and compassionate care in Arizona and Texas, where FastMed has an existing presence, while expanding this model to Florida and California, where the majority of the acquired clinics are located.
“Advising FastMed on this acquisition brought together our extensive healthcare M&A experience and our ability to efficiently and creatively facilitate sophisticated transactions. This acquisition will allow FastMed to continue expanding on its mission of improving delivery of affordable healthcare service to communities across several states,” said Steven Pidgeon, the DLA Piper partner who led the firm’s deal team.
In addition to Pidgeon (Phoenix), the DLA Piper team advising FastMed included partners Randy Peak (Dallas) and Ben Gipson (Los Angeles); senior counsel Mark Boxer (San Francisco); of counsel Nia Brown (Washington, DC); and associates Steven Autenrieth, Cameron Fine (both of Phoenix), Patrick Burri, Nicole Albertson (both of Silicon Valley), Alex Cates (Seattle) and Hayley Curry (Dallas).
With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 11 consecutive years, according to Mergermarket.
The firm's Healthcare sector consists of a multidisciplinary legal team with niche experience in health-related business and legal issues. The team regularly works with corporations and financial institutions, private investors, private equity groups, venture capital funds, institutional investors and portfolio companies in all types of healthcare transactions.